14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Monday, 6th May 2024 ZNTL stock ended at $11.72. This is 0.0854% more than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 5.63% from a day low at $11.55 to a day high of $12.20.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Zentalis Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Jun 19, 2020 $51.98 $55.82 $50.04 $53.12 991 932
Jun 18, 2020 $51.60 $54.89 $51.24 $52.10 236 407
Jun 17, 2020 $47.55 $54.20 $47.44 $52.25 321 015
Jun 16, 2020 $47.81 $51.20 $44.55 $47.27 161 795
Jun 15, 2020 $41.95 $47.62 $41.95 $46.88 237 414
Jun 12, 2020 $41.90 $45.02 $41.64 $41.95 197 861
Jun 11, 2020 $45.28 $45.58 $41.00 $41.07 168 214
Jun 10, 2020 $49.15 $49.75 $45.54 $45.93 131 231
Jun 09, 2020 $48.71 $51.51 $47.40 $49.38 196 704
Jun 08, 2020 $45.67 $49.96 $45.67 $47.14 128 782
Jun 05, 2020 $48.13 $50.15 $43.61 $45.60 199 066
Jun 04, 2020 $49.53 $52.99 $46.59 $48.49 165 526
Jun 03, 2020 $51.45 $52.08 $47.44 $50.81 202 184
Jun 02, 2020 $48.75 $51.94 $45.85 $51.46 124 775
Jun 01, 2020 $52.00 $52.43 $45.33 $49.35 278 841
May 29, 2020 $41.56 $52.43 $39.61 $52.22 338 222
May 28, 2020 $41.93 $43.09 $40.72 $41.30 164 010
May 27, 2020 $39.98 $42.38 $38.89 $41.72 105 736
May 26, 2020 $40.13 $40.88 $39.17 $39.64 88 660
May 22, 2020 $40.29 $41.38 $37.69 $39.07 162 376
May 21, 2020 $41.05 $42.45 $39.34 $40.04 86 929
May 20, 2020 $45.26 $48.61 $37.54 $41.07 305 778
May 19, 2020 $39.53 $44.80 $37.49 $44.66 196 718
May 18, 2020 $37.50 $40.45 $36.40 $39.65 116 084
May 15, 2020 $38.18 $42.83 $35.81 $35.87 171 261
Click to get the best stock tips daily for free!

About Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; Phase 1/2 clinical trial for the treatment of advanced solid tumors as a monotherapy and in an ... ZNTL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT